September 15, 2006—In a deal marking the first direct, Russian federal purchase of anti-retroviral HIV meds, British pharma company Glaxo Smith Kline announced plans today to provide the country with HIV meds Combivir, Epivir and Ziagen at a discounted price. The deal should help Russia meet its goal of getting 15,000 positive people on treatment by the end of 2006.
GSK and Russia Reach Discount Med Deal
Comments
Comments